Rankings
▼
Calendar
ACRS FY 2020 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ACRS
Aclaris Therapeutics, Inc.
$407M
FY 2020 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$6M
+53.3% YoY
Gross Profit
$1M
20.8% margin
Operating Income
-$51M
-785.4% margin
Net Income
-$51M
-787.0% margin
EPS (Diluted)
$-1.20
Cash Flow
Operating Cash Flow
-$39M
Free Cash Flow
-$39M
Stock-Based Comp.
$11M
Balance Sheet
Total Assets
$71M
Total Liabilities
$33M
Stockholders' Equity
$38M
Cash & Equivalents
$22M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$6M
$4M
+53.3%
Gross Profit
$1M
$172,000
+684.3%
Operating Income
-$51M
-$111M
+54.2%
Net Income
-$51M
-$161M
+68.4%
← Q4 2019
All Quarters
Q1 2020 →